The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival (OS) achieved with gemcitabine (G) or gemcitabine-abraxane (GA) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC) who received first line modified FOLFIRINOX (m-FFX) palliative chemotherapy.
 
Kyaw Lwin Aung
No Relationships to Disclose
 
Sean Creighton
No Relationships to Disclose
 
Adriana Fraser
No Relationships to Disclose
 
Anna Dodd
No Relationships to Disclose
 
Shari Moura
No Relationships to Disclose
 
Hamzeh Albaba
No Relationships to Disclose
 
Grainne M. O'Kane
No Relationships to Disclose
 
David W. Hedley
No Relationships to Disclose
 
Neesha C. Dhani
Honoraria - Celgene; Sanofi
Consulting or Advisory Role - Celgene; Incyte
 
Jennifer J. Knox
Honoraria - Novartis
Consulting or Advisory Role - Lilly; Merck
Research Funding - AstraZeneca